Artificial intelligence for diabetes care: current and future prospects

B Sheng, K Pushpanathan, Z Guan, QH Lim… - The Lancet Diabetes & …, 2024 - thelancet.com
Artificial intelligence (AI) use in diabetes care is increasingly being explored to personalise
care for people with diabetes and adapt treatments for complex presentations. However, the …

Dietary Modulations in Preventing Cardiometabolic Risk in Individuals with Type 2 Diabetes

N Dal, S Bilici - Current Nutrition Reports, 2024 - Springer
Abstract Purpose of Review Type 2 diabetes mellitus (T2DM) is a complex health issue
include obesity, high cholesterol, high blood pressure, and chronic inflammation that …

Prevalence and contributing factors of metabolic syndrome in rheumatoid arthritis patients

Z Bagheri-Hosseinabadi, F Moadab… - BMC Endocrine …, 2024 - Springer
Background Promoting prevalence of metabolic syndrome (MetS) in Rheumatoid arthritis
(RA) patients might occur secondary to RA therapy as well as sedentary life style. However …

The prevalence and contributing risk factors of coronavirus disease 2019 infection in patients with metabolic syndrome

Z Bagheri-Hosseinabadi, F Moadab, A Amiri… - BMC Endocrine …, 2023 - Springer
Background Components of metabolic syndrome (MetS) was reported to contribute to
severe and worse outcomes of coronavirus disease 2019 (COVID-19). Hereby, we …

Association between Interleukin‐6 Gene Polymorphism (rs1800795 and rs1800796) and Type 2 Diabetes Mellitus in a Ghanaian Population: A Case‐Control Study …

C Obirikorang, SY Lokpo… - BioMed Research …, 2024 - Wiley Online Library
Background. There is no conclusive evidence on the association between interleukin‐(IL‐) 6
gene polymorphism and type 2 diabetes mellitus (type 2 DM). Thus, this study is aimed at …

[HTML][HTML] Expert Opinion on Fixed Dose Combination of Dapagliflozin Plus Sitagliptin for Unmet Cardiovascular Benefits in Type 2 Diabetes Mellitus

S Ray, J Ezhilan, R Karnik, A Prasad… - Journal of …, 2024 - journals.lww.com
Type 2 diabetes mellitus (T2DM) is known to be associated with macrovascular (coronary
heart disease, stroke, and peripheral arterial disease) and microvascular complications …

[HTML][HTML] A Cross-Sectional Evaluation of Cardiovascular Risk Assessment in Type 2 Diabetes Mellitus Patients Using the Framingham Risk Score

MB Rathod, S Moukthika, AJ Karikunnel, K Harika… - Cureus, 2024 - ncbi.nlm.nih.gov
Background: The global burden of type 2 diabetes mellitus (T2DM) is continuously
increasing, particularly in India. The risk of cardiovascular disease (CVD) is higher in T2DM …

Cardiometabolic disease and cancer. Effects of body weight and diabetes

P Dikaiou - 2024 - gupea.ub.gu.se
Background: The rise in overweight and obesity rates is associated with an increase in
various forms of cardiovascular disease (CVD) and cancer. Moreover, an increasing …

Evaluation of the association of some circulating miRNA molecules in the metabolic syndrome

W Gouda, AEH Ahmed, AEHH Mohamed… - Qatar Medical …, 2025 - qscience.com
Purpose: The aim of this study was to investigate the possibility of including miRNA-371 and
miRNA-143 in the early detection and diagnosis of the extent of the metabolic syndrome …

Knowledge, attitude and practice of prevention of cardiovascular diseases in patients with type 2 diabetes in Dezful City in 2024

N Sarabi, A Moosavi, H Karimi… - The Journal of …, 2024 - publish.kne-publishing.com
Introduction: Knowledge, positive attitude, and proper practice are the most important factors
in controlling cardiovascular complications in chronic diseases such as diabetes. So, this …